Norbrook launches new Betafuse skin treatment for dogs

Norbrook Laboratories has announced the launch of Betafuse, a new gel product for treating canine skin conditions, in the UK, Ireland and mainland Europe.

The steroid-based antibiotic preparation is indicated for the treatment of surface pyoderma in dogs, including acute moist dermatitis – also known as hot spots – and intertrigo, or skin fold dermatitis.

It is being made available in 15g and 30g packages with a unique polyfoil tube, designed to reduce the likelihood of splitting and loss of product during use. Additionally, the in-use shelf life has been extended to eight weeks.

A number of product support materials are also being made available, including a guide for dog owners on how to apply Betafuse simply and effectively.

Lizzie Barnard, UK product manager at Norbrook, said: "Betafuse offers the prescribing veterinary surgeon greater choice and it complements our existing companion animal skin care portfolio."

Norbrook has committed to a 40 million pound multi-year investment programme to broaden its capabilities, with this scheme including a significant emphasis on new product development and facilities infrastructure.

With over 20 years of experience within the animal health market, we at Zenopa have the knowledge, skills and expertise to help find the right job for you. To find out more about the current animal health roles we have available, you can search for the latest job roles, register your details, or contact the team today.